Chemomab Therapeutics Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $12.5M
Liabilities Breakdown FY2020
Total Liabilities: $1.7M
Asset Breakdown
Total Assets: $12.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $11.7M | 93.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $152.0K | 1.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $650.0K | 5.2% |
Liabilities Breakdown
Total Liabilities: $1.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $93.0K | 5.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.6M | 94.4% |